Abbott India informs about movement in SMP

21 Jan 2025 Evaluate

Pursuant to Regulation 30 read with Clause 7 of Para A of Part A of Schedule Ill of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Abbott India has informed that Kunal Chowdhury - Commercial Director - GI Businesses has been promoted to another affiliate of the company effective February 1, 2025. He will serve his role as Commercial Director - GI Businesses with the company until January 31, 2025. Pursuant to the above, he will also cease to be the Senior Management Personnel of the Company effective close of business hours of January 31, 2025. The details required to be disclosed as per SEBI Circular No. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023 is enclosed.

The above information is a part of company’s filings submitted to BSE.

Abbott India Share Price

28869.35 42.50 (0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×